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Abstract: 
 
The use of styrene maleic acid (SMA) co-polymers to extract and purify transmembrane 
proteins, whilst retaining their native bilayer environment, overcomes many of the 
disadvantages associated with conventional detergent based procedures. This approach has 
huge potential for the future of membrane protein structural and functional studies. In this 
investigation we have systematically tested a range of commercially available SMA 
polymers, varying in both the ratio of styrene to maleic acid and in total size, for the ability 
to extract, purify and stabilise transmembrane proteins. Three different membrane proteins 
(BmrA, LeuT and ZipA) which vary in size and shape were used. Our results show that several 
polymers can be used to extract membrane proteins comparably to conventional 
detergents. A styrene:maleic acid ratio of either 2:1 or 3:1, combined with a relatively small 
average molecular weight (7.5-10 kDa) is optimal for membrane extraction, and this appears 
to be independent of the protein size, shape or expression system. A subset of polymers 
were taken forward for purification, functional and stability tests. Following a one-step 
affinity purification SMA 2000 was found to be the best choice for yield, purity and function. 
However the other polymers offer subtle differences in size and sensitivity to divalent 
cations that may be useful for a variety of downstream applications. 
 
 
 
 
 
Summary statement: 
 
Several commercially available SMA polymers are capable of extracting and purifying 
transmembrane proteins. SMA 2000 is the best choice in terms of solubilisation efficiency, 
purity and yield. However, alternative polymers may allow fine tuning of the method for 
downstream applications. 
 
 
 
Short title: Effect of polymer variation on SMALP solubilisation of membrane proteins 
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Introduction: 
 
The study of the structure and function of transmembrane proteins lags significantly behind 
that of soluble proteins. In large part this is because, in contrast to soluble proteins, there is 
a need to extract or solubilise these proteins from their lipid bilayer environment. 
Conventionally this has been achieved using detergents/surfactants which can disrupt the 
bilayer structure and form micellar structures around the hydrophobic transmembrane 
regions of the protein. Whilst this approach has yielded many results the use of detergents 
is not without significant challenges. In the detergent solubilised state membrane proteins 
tend to have limited stability and often exhibit much reduced activity when compared to 
native forms. This is the result of the delicate balance that needs to be struck to achieve 
efficient extraction without denaturing the protein. This denaturation results from the 
detergent being unable to reproduce the complex physical environment of the membrane in 
which the protein has evolved to function, and detergents often strip all lipids from the 
protein. 
 
Recently we and others have shown that a new approach to membrane protein extraction 
using a styrene maleic acid (SMA) co-polymer can overcome many of these problems [1-3]. 
The SMA polymer spontaneously inserts into membranes and forms small discs of bilayer 
surrounded by the polymer, termed SMA lipid particles (SMALPs). Membrane proteins 
extracted in these discs can be purified by affinity chromatography whilst retaining their 
annular lipid bilayer environment [4-9]. There are several examples in the literature showing 
proteins in SMALPs that are functional and  more thermostable than detergent-solubilised 
proteins [4-6, 9]. The SMALP disc structure is well suited for many biophysical and 
spectroscopic techniques [4, 7, 10, 11], as well as structural studies using electron 
microscopy [4, 12]. There are of course some limitations. Firstly the size of the SMALPs is  
typically around 10 nm diameter [1, 5, 13], which can be too small for some large proteins 
or complexes [14]. Secondly the SMALP structure is sensitive to divalent cations such as 
Mg2+, which above a certain concentration causes the SMA to precipitate out of solution [3, 
4]. 
 
Many different SMA co-polymers are commercially available, which can vary in the ratio of 
styrene:maleic acid and in their total length and size. To date the polymers used to extract 
membrane proteins are SMA(2:1) [1, 4-7, 9, 12] and SMA(3:1) [8, 10, 11, 15, 16], which have 
styrene to maleic acid ratios of 2:1 and 3:1 , and are relatively small with average molecular 
weights of 7.5 kDa and 10 kDa respectively. In this study we systematically assessed a 
selection of SMA co-polymers (Table 1), with varying ratios of styrene:maleic acid, and a 
range of molecular weights. We aimed to determine whether these polymers were effective 
for extracting and purifying membrane proteins, and if so whether they could overcome the 
limitations in size and Mg2+ sensitivity of the SMA copolymers currently in use.  
 
Our study assessed the performance of these polymers in the extraction process for three 
different bacterial membrane proteins of varying size and structure, namely BmrA, LeuT and 
ZipA. BmrA is a multidrug efflux pump of the ABC (ATP Binding Cassette) superfamily from 
Bacillus subtilis [17]. It forms a homodimer, where each monomer provides 6 
transmembrane alpha-helices and a cytosolic nucleotide binding domain. Thus it has a large 
transmembrane region and a large cytosolic region. LeuT, an amino acid:sodium symporter 
of the NSS (neurotransmitter:sodium symporter) family from Aquifex aeolicus, comprised of 
12 transmembrane helices is located almost entirely within the membrane [18]. Finally ZipA, 
a membrane tether involved in cell division in E. coli, has just a single transmembrane helix 
with a large cytosolic domain [19]. 
  
Experimental procedures: 
SMA preparation 
SMA 2000, SMA 1000 and SMA 3000 were obtained from Cray Valley (Exton, PA, USA). 
XZ09008, XZ09006, SZ25010, SZ40005, SZ42010, SZ33030, SZ28065 and SZ28110 were from 
Polyscope (Geleen, NL). The commercially available polymers are provided as styrene maleic 
anhydride co-polymer and need to be converted to the styrene maleic acid by hydrolysis in 
NaOH [20, 21]. A solution of each styrene maleic anhydride copolymer 10% (w/v) in 1M 
NaOH was refluxed for 2 hours and allowed to cool to room temperature. The polymers 
were precipitated by the addition of excess concentrated HCl and washed extensively with 
distilled water. Washed polymer was dissolved in 0.6M NaOH to give a pH of 8, and freeze-
dried. Styrene maleic acid copolymer powder was stored at room temperature.  
 
Protein production & membrane preparation 
C41 (DE3) E.coli cells were transformed with the vector pET23b-BmrA containing the gene 
for BmrA expressed as a fusion to a C-terminal His6 tag (kind gift from Prof. Jean-Michel 
Jault, IBCP, Lyon). BL21 (DE3) E.coli cells were transformed with the vector pET101-ZipA with 
a V5 epitope and C-terminal His6 tag (kind gift from Dr David Roper, University of Warwick) 
or with pET16b-LeuT with an N-terminal His8 Tag (kind gift from Prof. Harald Sitte, Medical 
University of Vienna).  
Small overnight cultures (5 ml) were used to inoculate 1 litre flasks of Luria Broth 
supplemented with 100 µg/ml ampicillin and grown at 37°C, 200 rpm until OD600 reached 
0.6. Protein synthesis was induced by the addition of 0.5 mM IPTG and the temperature was 
reduced to 25°C. Cells were harvested 18-20 hours later by centrifugation (6000 g, 10 min).  
The E. coli cell pellets were re-suspended in buffer 1 (50mM Tris at a pH 7.4, 250 mM 
sucrose, 0.25 mM CaCl2) supplemented with protease inhibitors (1 µM pepstatin, 1.3 µM 
benzamidine, 1.8 µM leupeptin). Cells were disrupted on ice using sonication. Unbroken 
cells and debris were removed by a low speed spin (650 g, 20 min, 4°C), then membranes 
harvested by ultracentrifugation (100,000 g 20 min, 4°C). Membranes were resuspended in 
buffer 2 (20 mM Tris pH8, 150 mM NaCl) at a final concentration of 60 mg/ml wet 
membrane weight, aliquoted and stored at -80°C. 
 
Solubilisation trials 
Initial trials compared SMA 2000 with the conventional detergents octyl-β-D-glucoside (OG) 
and dodecyl-β-D-maltoside (DDM). Membranes containing each target protein (30 mg/ml 
wet weight) in buffer 2 were mixed with 2.5% (w/v) SMA 2000, 2% (w/v) OG (Sigma) or 2% 
(w/v) DDM (VWR) for 1 hour at room temperature, with gentle shaking. Samples were then 
centrifuged (100,000g, 20 min) and the supernatant containing solubilised protein was 
retained. The pellet containing insoluble material was resuspended in the same total 
volume of buffer 2 supplemented with 2% (w/v) SDS. Samples of soluble and insoluble 
material were analysed by Western blot, probed with an anti-his 1°primary antibody 
(1:1000, R&D systems). Blots were visualised using a 2o antibody of either anti-mouse 
Alkaline phosphate and BCIP/NBT (Sigma) or anti-mouse HRP and SuperSignal West 
chemiluminescent kit (ThermoFisher). The percentage of total protein solubilised was 
determined from the Western blots using densitometry (ImageJ). 
A similar procedure was followed to screen the different SMA polymer variations. Each 
polymer was used at a final concentration of 2.5% (w/v), and the amount of protein 
solubilised was normalised to that obtained with SMA 2000. 
 
Ni-NTA affinity Purification 
Solubilised protein was mixed with HisPur Ni2+-NTA resin (ThermoFisher) at a ratio of 100 µl 
resin per ml of solubilised protein, at 4°C overnight with gentle rotation. The sample was 
transferred to a gravity flow column (Machery-Nagel) and the flow through containing 
unbound material collected. The resin was washed 5 times with 10 bed volumes (BV) of 
buffer 2 supplemented with 20 mM imidazole, twice with 10 BV buffer 2 containing 40 mM 
imidazole and once with 2 BV buffer 2 supplemented with 60 mM imidazole. Proteins were 
eluted with buffer 2 supplemented with 200 mM imidazole and six fractions of 1 BV were 
collected. For purifications using DDM, all wash and elution buffers were also supplemented 
with 0.1 % (w/v) DDM.  Fractions were analysed using 7.5% SDS-PAGE and InstantBlue stain 
(Expedeon). Elution fractions containing the target protein were pooled and stored at 4°C. 
 
Purified protein quantification 
The concentration of purified protein samples was determined from SDS-PAGE using BSA as 
a standard as described previously [22]. Unlike many colorimetric methods, this method 
does not suffer from interference from lipids, imidazole, or SMA. Briefly, samples (10 µl and 
20 µl) of purified proteins were separated using 7.5% SDS-PAGE alongside BSA standards 
(0.25, 0.5, 0.75, 1, 1.25 µg), and stained with InstantBlue (Expedeon). Intensity of each band 
was analysed by densitometry (ImageJ), and a standard curve constructed for BSA. Using the 
standard curve the concentration of purified LeuT/ZipA/BmrA was calculated. From the 
concentration, the yield of purified protein per litre of culture could be calculated. 
To estimate the purity of each target protein, 1-2 µg of purified protein sample was loaded 
on 7.5% SDS-PAGE and stained with InstantBlue. The whole lane was analysed by 
densitometry, and the intensity of the protein of interest as a percentage of the total 
staining intensity was determined. 
 
BmrA substrate binding assay  
Substrate binding to BmrA was measured using a tryptophan fluorescence quenching assay 
as described previously [17]. Using centrifugal filter concentrators (Amicon Ultra, 30K cutoff) 
purified BmrA was concentrated and exchanged into buffer 2 to remove imidazole. 
Tryptophan fluorescence of BmrA (50 µg/ml) was monitored using a Perkin Elmer LS55 
fluorimeter, with an excitation wavelength of 280 nm (slit width 10 nm), and emission 
measured at 310-400 nm (slit width 20 nm). Fluorescence quenching by successive additions 
(1 – 50 µM) of Hoechst 33342 or doxorubicin was measured at 335 nm (λmax). Fluorescence 
intensities were corrected for the effects of dilution and the inner filter effect using N-acetyl 
tryptophanamide. Results were analysed by non-linear regression using Graphpad Prism 
(Graphpad Software Inc.) to fit a one-site binding hyperbola. 
 
Thermostability 
The aggregation of purified BmrA upon heating was measured using right angle light 
scattering. BmrA (50 µg/ml) was heated from 25°C - 95°C in increments of 10°C for 10 
minutes each. After incubation at each temperature the light scattering was measured using 
a Perkin Elmer LS55 fluorimeter at a wavelength of 390 nm (slit width10nm). 
Thermostability was also monitored by heating samples of purified BmrA (50 µg/ml) at 
specific temperatures for 10 minutes, followed by centrifugation to remove aggregates 
(10,000g, 10 min). Soluble protein remaining in the supernatant was analysed by SDS-PAGE. 
Mg2+ sensitivity assay 
SMA solubilised and purified ZipA (50 µg/ml) was mixed with various concentrations of 
MgCl2 (0-10 mM) at room temperature for 10 min. Samples were centrifuged (100,000g, 20 
min, 4 °C), the supernatant containing soluble protein was harvested, and the pellet 
containing insoluble material was resuspended in the same volume of buffer 2. Samples of 
both soluble and insoluble protein were run on SDS-PAGE, stained with InstantBlue, and the 
percentage of protein remaining in solution was calculated by densitometry. 
 
Dynamic light scattering (DLS) 
Purified LeuT was concentrated using Amicon Ultra filter concentrators to 100 µg/ml in 20 
mM Tris HCl 150 mM NaCl pH 8 buffer. DLS data were recorded using a Malvern Zetasizer 
Nano S (633 nm) and 1.0 cm pathlength disposable plastic cuvettes (Brand BMBH, 
Germany). Measurements were taken at 20°C with 300 s equilibration time. Automated 
instrument parameters were used. Each measurement was repeated at least 11 times.  
 
Statistical analysis 
Statistical analysis was carried out using GraphPad Prism and used an ANOVA for multiple 
comparisons, with a Tukey post-hoc test; p<0.05 was considered significant. 
 
 
  
Results: 
Solubilisation of proteins using SMA 2000 and conventional detergents 
The initial aim of the study was to determine if SMA 2000, the most widely used SMA 
polymer to date, was able to effectively solubilise three different membrane proteins: LeuT, 
ZipA and BmrA. It can be seen in Figure 1 that for each protein approximately 55% of the 
total was solubilised using 2.5% (w/v) SMA 2000. This was comparable to the solubilisation 
efficiency observed for each protein using the conventional detergent dodecylmaltoside 
(DDM). For ZipA a similar solubilisation efficiency was also observed for the shorter chain 
conventional detergent octyl glucoside (OG), however for LeuT and BmrA the solubilisation 
with OG was significantly less efficient (p<0.05, ANOVA).  
 
Screening SMA polymer variations for protein solubilisation 
Having established that SMA 2000 could successfully solubilise all three proteins, the next 
step was to screen the new SMA polymers to establish if they were capable of extracting 
membrane proteins. The new SMA polymers tested vary in size from 5 to 110 kDa, and had 
ratios of styrene:maleic acid ranging from 3:1 to 1:1 (Table 1). As shown in Figure 2, three of 
the polymers, SMA 3000, XZ09008 and SZ25010, stand out as being effective at solubilising 
membrane proteins, giving results that are comparable to SMA 2000. SMA 3000 has been 
previously used to successfully solubilise several membrane proteins [8, 10, 11, 15, 16], so it 
is not surprising that it is effective. XZ09008 and SZ25010 have very similar properties to 
SMA 3000, with a 3:1 styrene:maleic acid ratio and a reported molecular weight of 10kDa. 
However most of the other polymers were not effective at all. The larger polymers, 
SZ33030, SZ28065 and SZ28110, with average molecular weights of 30-110 kDa were very 
poor at extracting proteins, despite having styrene:maleic acid ratios comparable to SMA 
2000 and SMA 3000. The small polymers with a high percentage of maleic acid, SMA 1000, 
SZ40005 XZ09006 and SZ42010, were also not particularly effective at solubilising proteins, 
despite having similar molecular weights to SMA 2000 and SMA 3000. It is interesting to 
note that the results are strikingly similar for all three target proteins, despite their 
differences in size and shape. It appears that the effectiveness of each polymer is not 
protein specific. The target proteins tested here were all expressed in E. coli, however the 
same pattern of results are also observed for MRP4/ABCC4 expressed in Sf9 insect cells and 
MRP1/ABCC1 in H69AR cancer cells (Supplementary Figure 1), showing the effectiveness of 
each polymer is not expression system-specific. Thus it seems that a styrene:maleic acid 
ratio of 2:1 or 3:1, and a molecular weight of 7.5-10 kDa is optimal for membrane protein 
solubilisation.  
 
Purification of membrane proteins 
The three polymers able to solubilise the membrane proteins effectively (SMA 3000, 
XZ09008 and SZ25010) were taken through to protein purification trials, alongside SMA 
2000 and the conventional detergent DDM. Also included was the polymer XZ09006, which 
solubilised almost half as much protein as SMA 2000. Each protein was purified by a single 
step Ni2+-NTA affinity chromatography procedure as shown in Figure 1A. The concentration 
and volume of purified protein obtained were used to calculate the yield per litre culture for 
each protein with each solubilisation agent and the average results are shown in Figure 3B. 
The average yield using SMA 2000 was 1.2±0.1 mg/l, 1.0±0.1 mg/l and 0.8±0.1 mg/l, for 
ZipA, BmrA and LeuT respectively. With the conventional detergent DDM, the yields were 
comparable to SMA 2000. However for each of the other polymers the yield of pure protein 
was decreased compared to SMA 2000. XZ09006 gave the lowest yield for each protein. This 
is not surprising given that XZ09006 solubilised half as much protein as SMA 2000 or DDM. 
However, SMA 3000, XZ09008 and SZ25010 were able to solubilise almost the same amount 
of protein as SMA 2000. The decrease in yield observed must be due to a loss at some point 
during the purification procedure. 
The purity of protein samples obtained with this single step affinity procedure was also 
analysed. It has previously been reported that SMA 2000 typcially yields a more pure sample 
than conventional detergents [4]. This observation was reiterated with all three of the 
proteins studied here, and is illustrated in Figure 3C, where a sample of BmrA purified using 
DDM clearly contains many more contaminating proteins than the sample purified using 
SMA 2000. The average measurements for the degree of purity, measured using 
densitometric analysis of gels loaded with 1-2 µg total protein, are shown in Figure 3D. The 
purity of each protein obtained using DDM was significantly lower than when using SMA 
2000. Thus despite achieving similar total yields with DDM and SMA 2000, the purity of the 
SMA 2000 encapsulated proteins was superior. The polymers XZ09008 and XZ09006 also 
gave samples of significantly lower purity than SMA 2000, however SMA 3000 and SZ25010 
showed no significant differences to SMA 2000, despite the lower yields.  
 
Ligand binding 
We investigated whether the different polymers tested affected the membrane protein 
structure and function by measuring ligand binding to BmrA using a tryptophan 
fluorescence quenching assay [17]. Two substrates were tested: Hoechst 33342, and 
doxorubicin. The average binding affinity (Kd) and maximal quenching (%) parameters are 
shown in Table 2. It can be seen that BmrA in DDM micelles or SMA 2000 SMALPs has 
comparable ligand-binding properties, displaying a greater affinity and larger degree of 
quenching for Hoechst 33342 than doxorubicin, as has been previously observed [17]. 
XZ09006 purified BmrA also shows no differences to SMA 2000 or DDM. However for SMA 
3000 (Figure 4D), XZ09008 and SZ25010 a significantly lower affinity is observed for Hoechst 
33342. BmrA encapsulated within these polymers still appears to bind Hoechst 33342: the 
same maximal degree of quenching is obtained, but with a lower affinity. Interestingly only 
the Hoechst 33342 binding is affected, while all samples show comparable affinities and 
maximal degree of quenching with doxorubicin. 
 
Influence of polymer type on SMALP Size  
One important aspect of the SMALP method is the size of the particle that contains the 
protein. Larger particles could allow proteins with more extensive transmembrane domains 
to be solubilised (currently the limit seems to be 36 transmembrane helices [12]). 
Conversely, smaller particles might be of more use in techniques like NMR where rapid 
tumbling times are important.  
To measure the size of the SMALPs produced with the various polymers we used dynamic 
light scattering (DLS), and the protein LeuT, since this protein is predominantly located 
within the membrane bilayer. This allowed the disc size to be measured with minimal 
interference from cytosolic regions of the protein. The results in Figure 4A show that SMA 
2000 SMALPs display an average diameter of 8-9 nm, whereas SMA 3000, XZ09008 and 
SZ25010 give a smaller diameter of approximately 5 nm, despite these polymers having a 
larger molecular weight than SMA 2000. 
 
Influence of polymer type on stability 
A key observation of previous SMALP encapsulations has been an increase in stability of the 
encapsulated protein. In this experiment we examined whether different SMA types confer 
different stabilities. The thermostability of purified samples was assessed using a right-angle 
light scattering assay which was able to measure the thermally induced aggregation of the 
sample. As shown in Figure 4B, BmrA purified in DDM micelles showed a clear temperature 
dependent increase in aggregation, however this was not observed when BmrA was purified 
within SMA 2000 SMALPs. To confirm that the increase in light scattering was due to protein 
aggregation, samples were also analysed by centrifugation and SDS-PAGE (Supplementary 
Figure 2). A clear loss of DDM-solubilised BmrA from solution is seen at 65°C whereas this is 
not the case for BmrA in SMA 2000 SMALPs.Similar light scattering results to those obtained 
with SMA 2000 were also observed for BmrA within SMA 3000 and XZ09008 polymers. For 
SZ25010 and XZ09006 there was a slight increase in scattering at the highest temperatures, 
but this was very small when compared to the DDM sample. 
 
Susceptibility of SMALPs to Mg2+ 
One of the deficiencies of the SMALP is its susceptibility to Mg2+.[4]. Magnesium ions are 
thought to bind to the SMA polymer surrounding a SMALP causing the polymer and the 
protein it encapsulates to precipitate out of solution. We examined the sensitivity to 
magnesium (Mg2+) of protein-encapsulated by other SMA types. As shown in Figure 4C, for 
ZipA purified within SMA 2000 SMALPs, a concentration of MgCl2 below 4 mM is tolerated, 
but at concentrations above this, a dose-dependent loss of solubility is observed. ZipA 
within XZ09006 SMALPs displays a similar response to Mg2+. However ZipA within SMA 
3000, X09008 and SZ25010 SMALPs is even more sensitive to Mg2+, with concentrations of 
1-2 mM causing complete precipitation. 
 
  
Discussion: 
The recent application of SMA polymers for solubilisation and purification of membrane 
proteins has the potential to revolutionise the field of membrane protein structural and 
functional studies, resolving many issues currently posed by the use of conventional 
detergents. The SMALPs provide a solubilisation method that preserves the  lipid bilayer 
environment of membrane proteins, making it possible to maintain near native structure, 
function and stability.  
 
In this study we aimed to screen a variety of commercially available SMA polymer variations, 
to establish which features of the polymer are important for efficient protein extraction, 
purification and downstream analysis. We used a set of three different membrane proteins, 
with varying size and shape to reduce protein specific issues.  
 
The first step was to assess the solubilisation efficiency for each protein with conventional 
detergents compared to SMA 2000. The solubilisation of both LeuT and BmrA was less 
effective with the shorter chain conventional detergent OG. This is not surprising since it is 
well established that short chain detergents are less effective for initial solubilisation, but 
better for crystallography. Notably a published LeuT crystal structures utilised DDM to 
solubilise the protein, before switching to OG for crystallization [18]. For each of the three 
proteins in this study, the solubilisation efficiency with the conventional detergent DDM was 
just over 50%. This is comparable to that reported previously for BmrA with DDM [17]. SMA 
2000 solubilised approximately 55% of each protein, thus SMA 2000 is comparable to or 
better than conventional detergents. This concurs with a previous study of other protein 
targets [4]. 
 
During the solubilisation screening, none of the alternative polymers offered an 
improvement upon the solubilisation efficiency achieved with SMA 2000, though SMA 3000, 
XZ09008 and SZ25010 did give results comparable to SMA 2000. These three polymers each 
have a styrene:maleic acid ratio of 3:1, and an average molecular weight of 10 kDa, 
compared to SMA 2000, which has a 2:1 ratio of styrene:maleic acid and is a little smaller at 
7.5 kDa. It should be considered however that all of the commercially available polymers 
used here have high polydispersity indexes and the molecular weights detailed in Table 1 
are the average of a mixture of different sizes. This results from the methods used to 
synthesise the polymers, which yield samples containing a distribution of sizes, and also 
variations in the sequence of styrene and maleic acid groups [3]. We do not currently know 
if all of the different polymers within each distribution are functional in solubilisation and 
forming SMALPs or if it is a small subset. However given that more defined preparations are 
not easily available it was reasonable to test the commercially available polymers. The 
results showed clearly that a styrene:maleic acid ratio of either 2:1 or 3:1, combined with an 
average molecular weight of 7.5-10 kDa was required for efficient solubilisation of 
membrane proteins, and any deviation from this resulted in poor protein extraction.  
 
Ni2+-NTA affinity purification of proteins within SMA 2000 SMALPs gave yields that were 
comparable to those obtained using DDM, however the purity achieved using SMA 2000 
was significantly higher than that achieved using DDM, as has been reported previously for 
other proteins [4]. Surprisingly the yields of protein achieved using SMA 3000, XZ09008 and 
SZ25010 were lower than with SMA 2000, despite showing comparable solubilisation 
efficiencies, suggesting that with these polymers protein was lost during the purification 
procedure. One possibility is less efficient binding to the Ni2+-NTA resin, as it is known that 
the binding interaction between the SMALP-protein and the Ni2+-NTA resin can be of low 
affinity [3]. An alternative could be that SMALPs formed from these polymers are less stable 
than SMA 2000 SMALPs, leading to loss of protein from solution during washing steps. It 
remains to be determined at which stage(s) the protein is lost, however under the standard 
conditions tested here it would seem that SMA 2000 gives the greatest yield and purity of 
purified membrane protein. 
 
The size of SMALPs formed using SMA 2000 reported in the literature shows considerable 
variation [3]. This may be the result of differences in the method used to make the 
measurement. DLS [1, 7, 23], small angle neutron scattering [13] and electron microscopy 
[1, 5, 7] have all been used. For some proteins these measurement are complicated by the 
presence of large cytosolic domains which will contribute to the overall dimensions. To 
overcome this we used LeuT-SMALPs, where the protein is predominantly located within 
the bilayer region. Our results using DLS gave an average diameter for LeuT-SMA 2000 of 8-
9nm, which is smaller than typical reports of 10-12nm. However it compares well with the 
diameter of 9 nm reported for PagP-SMALPs in Knowles et al [1], and the small angle 
neutron scattering studies of lipid-only SMALPs in Jamshad et al [13]. Surprisingly we found 
that LeuT-SMALPs formed from the larger polymers SMA 3000, XZ09008 and SZ25010 gave 
smaller diameters of approximately 5 nm. This is in contrast to previous reports where SMA 
3000 was used and diameters of 12 nm were reported [10, 15]. Possible explanations for 
this could include the formation of SMALP-SMALP interactions to form dimers, as has been 
observed previously [12], methodological and sample preparation differences for DLS and 
electron microscopy that have previously been shown to give different measurements for 
the same sample [1, 13], or that the polymer can form different size particles depending on 
the size of the protein encapsulated. It has also been shown using lipids only that if less SMA 
is used during solubilisation, larger SMALPs can actually be formed, and the size of the 
particle formed depends on the ratio of SMA/lipid  [24, 25]. In our study we have used an 
excess of SMA polymer at 2.5% (w/v) with membranes at 30 mg/ml (wet pellet weight). We 
have shown previously that lower concentrations of SMA, down to approximately 1% (w/v) 
are still effective for protein solubilisation under these conditions, but below this 
solubilisation is less efficient [21]. It will be interesting in the future to establish if conditions 
can be tailored to produce larger SMALPs whilst still extracting sufficient protein. 
 
Interestingly we also observed differences in BmrA ligand binding and ZipA Mg2+ sensitivity 
for the same three polymers, SMA 3000, XZ09008 and SZ25010, compared to SMA 2000. 
BmrA within SMA2000 SMALPs bound both Hoechst 33342 and doxorubicin in a manner 
comparable to DDM solubilised BmrA, and gave parameters similar to previous published 
studies [17]. However, although BmrA within SMA 3000, XZ09008 and SZ25010 polymers 
was able to bind the substrate Hoechst 33342, a lower binding affinity was observed. This 
was not the case for the substrate doxorubicin. It is not totally clear why this difference was 
observed, but BmrA is a multidrug transporter, and possesses multiple distinct drug binding 
sites. Like with its relative P-lgycoprotein/ABCB1, it is likely Hoeschst 33342 and doxorubicin 
bind to different sites [26]. The different physical properties of the various polymer SMALPs 
seem to have different effects on the two drug binding sites.  
 
SMALPs formed from SMA 2000 are known to be sensitive to divalent cations such as Mg2+. 
It is plausible to think that the two carboxyl groups of a maleic acid chelate Mg2+, possibly 
inducing strain or conformational change in the SMA surrounding a SMALP. If this occurs to 
too many of the maleic acid groups protruding from a single SMALP it causes the SMA to 
precipitate. Without the SMA belt surrounding the lipid disc, it becomes unstable and the 
encapsulated proteins and lipids also precipitate. For ZipA within SMA 2000 SMALPs this 
occurs at concentrations exceeding 5 mM MgCl2 (Figure 4C). However for ZipA in SMA 3000, 
XZ09008 and SZ25010 this precipitation occurs at lower concentrations (≤1 mM). It is 
possible this difference is due to the smaller size discs obtained with these polymers, as 
tighter wrapping around a smaller disc might be perturbed more significantly by chelating 
Mg2+. 
 
To summarize, this study has shown that several commercially available SMA polymers are 
capable of extracting and purifying membrane proteins. However, our results suggest that 
SMA 2000 is the best choice in terms of solubilisation efficiency, purification yield, purity 
and protein function. None of the other polymers tested were able to overcome the current 
limitations of SMA 2000, such as sensitivity to divalent cations or limited size. In fact the 
other polymers were more sensitive to Mg2+, and produced smaller diameter discs. 
Nonetheless there may be occasions when this would be beneficial. For example if you 
wanted to analyse the annular lipids associated with a protein, extraction with an SMA that 
gave a smaller disc would contain fewer total lipids, and only retain those most closely 
associated with the protein. A structure that is less stable or more easily disrupted may be 
helpful for reconstituting SMALP-encapsulated proteins into proteoliposomes or other 
bilayer systems for functional analysis. Alternatively for structural studies, a smaller disc size 
could be beneficial. For electron microscopy a smaller belt of lipids would mask the protein 
less, and for crystallization trials fewer lipids and a more easily disrupted structure may be 
beneficial for forming crystals, whereas for NMR a smaller disc size might be beneficial in 
giving more rapid tumbling times. Thus, while SMA 2000 remains the first choice for protein 
purifications, understanding the properties of alternative polymers may allow us to fine 
tune the method for specific downstream applications. 
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Table 1.  Properties of the polymers. Values for the % maleic acid content, and the mass-
average molecular weights for each polymer, as specified by the suppliers. 
 
Polymer name % maleic acid 
content 
Average molecular 
weight (kDa) 
Cray Valley   
SMA 1000 50 5.5 
SMA 2000 33 7.5 
SMA 3000 25 9.5 
Polyscope   
XZ09006 40 7.5 
XZ09008 25 10 
SZ40005 42 5 
SZ25010 25 10 
SZ42010 42 10 
SZ33030 33 30 
SZ28065 28 65 
SZ28110 28 110 
 
 
  
 Table 2.  Binding assay parameters for BmrA. Quenching of the intrinsic tryptophan 
fluorescence of BmrA (50µg/ml), purified with each polymer or DDM, upon binding of 
substrates Hoechst 33342 or doxorubicin was measured.  Data are mean±sem and n≥3. Data 
were analysed using an ANOVA, * p<0.05, ** p<0.01  significantly different to SMA 2000. 
 
Polymer/detergent Hoechst 33342 Doxorubicin 
 Kd (µM) Maximal 
quenching (%) 
Kd (µM) Maximal 
quenching (%) 
DDM 5.9 ± 1.4 55 ± 4 16 ± 5 22 ± 4 
SMA 2000 4.0 ± 0.8 52 ± 5 16 ± 2 39 ± 5 
SMA 3000  16 ± 2 * 49 ± 6 16 ± 5   39 ± 10 
XZ09008   18 ± 3** 51 ± 9 12 ± 5 31 ± 8 
SZ25010  15 ± 5 * 47 ± 5 21 ± 9   30 ± 10 
XZ09006 4.5 ± 1.2 44 ± 5 15 ± 6 29 ± 7 
 
 
  
Figure 1. Comparison of SMA2000 with conventional detergents for 
extraction/solubilisation efficiency.  Membranes (30mg/ml wet weight) from E.coli cells 
overexpressing each protein, were solubilised with either 2.5% (w/v) SMA 2000, 2% (w/v) 
octyl glucoside (OG) or 2% (w/v) dodecylmaltoside (DDM) in 20 mM Tris pH8, 150 mM NaCl 
for 1 hour at room temperature, whilst gently shaking. Samples were centrifuged at 
100,000g for 20 min at 4°C.  The supernatant containing solubilised protein was harvested, 
and the pellet containing insoluble material was resuspended in an equal volume of 2% 
(w/v) SDS. Samples of both solubilised and insoluble material were run on a Western blot 
using an anti-his 1° antibody (1:1000), and the % of total protein solubilised determined 
using densitometry. Data are mean±sem, n≥3. 
 
Figure 2. Screen of SMA polymer variants for extraction of membrane proteins compared 
to SMA 2000.  Membranes (30mg/ml wet weight) from E.coli cells overexpressing each 
protein, were incubated with 2.5% (w/v) of each polymer for 1 hour at room temperature, 
whilst gently shaking. Samples were centrifuged at 100,000g for 20 min at 4°C.  The 
supernatant containing solubilised protein was harvested. Samples were run on a Western 
blot using an anti-his 1° antibody (1:1000), and the degree of solubilisation relative to 
SMA2000 determined by densitometry. Data are mean±sem, n≥3. 
 
Figure 3. Yield and purity obtained using SMA polymer variants. Solubilised proteins were 
mixed with Ni-NTA resin (100 µl resin per ml solubilised protein) overnight at 4°C, 
transferred to a gravity flow column and washed extensively with buffer supplemented with 
20-60 mM imidazole. Proteins were eluted using buffer supplemented with 200 mM 
imidazole. A; example purification gel for ZipA solubilised using SZ25010, showing 
solubilised protein (sol), flowthrough (FT), 20 mM imidazole washes and 200 mM imidazole 
elution fractions on a 7.5% SDS-PAGE stained with InstantBlue. B; The concentration of 
purified protein was determined and total yield per L culture calculated. Data are 
mean±sem, n≥3. C; SDS-PAGE stained with InstantBlue highlighting the difference in purity 
obtained for BmrA solubilised and purified using SMA 2000 compared to DDM. D; Degree of 
purity for each protein preparation was determined using densitometry. Data are 
mean±sem, n≥3. Data were analysed using an ANOVA with a Tukey post-hoc test, * p<0.05, 
** p<0.01  yield/purity is significantly lower than that obtained using SMA2000. 
 
Figure 4. Size & stability of SMALPs formed from the different polymers. A; LeuT 
solubilised and purified with each polymer and DDM was analysed using dynamic light 
scattering. Results are presented as number-weighted particle size distributions. B; Thermal 
aggregation of BmrA purified using each polymer or DDM was monitored using right angle 
light scattering at a wavelength of 390nm. C; Magnesium sensitivity of purified ZipA with 
each polymer was assessed by centrifugation at 100,000g 20 min, and samples of both 
supernatant and pellet were run on SDS-PAGE and analysed by densitometry. D; Binding of 
Hoechst 33342 to BmrA extracted and purified with either SMA 2000 (closed circles) or SMA 
3000 (open circles) as monitored by tryptophan fluorescence quenching. Data are 
mean±sem, n≥3. 
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Supplementary Information 
 
 
Supplementary Figure 1. Solubilisation of proteins from Sf9 insect cells or mammalian cells using 
SMA polymers and conventional detergents. A; Comparison of solubilisation efficiency of SMA 2000 
and conventional detergents. B; Screening of polymer variations for solubilisation. Membranes 
(30mg/ml wet weight) from Sf9 cells overexpressing MRP4, or H69AR cells expressing MRP1, were 
mixed with either 2.5% (w/v) SMA polymers, 2% (w/v) octyl glucoside (OG) or 2% (w/v) 
dodecylmaltoside (DDM) in 20 mM Tris pH8, 150 mM NaCl for 1 hour at room temperature, whilst 
gently shaking. Samples were centrifuged at 100,000g for 20 min at 4°C.  The supernatant containing 
solubilised protein was harvested, and the pellet containing insoluble material was resuspended in 
an equal volume of 2% (w/v) SDS. Samples of both solubilised and insoluble were run on a Western 
blot using an anti-his 1° antibody (1:1000) or QCRL-1 antiMRP1 antibody (1:5000), and the % of total 
protein solubilised or degree of solubilisation relative to SMA2000 determined using densitometry. 
Data are mean±sem, n≥2.   
  
 
 
 
Supplementary Figure 2. Thermostability of BmrA in SMALP compared to detergent. Pure BmrA (50 
µg/ml) in either DDM micelles or SMA2000 SMALPs was heated for 10 mins at 25°C or 65°C and then 
centrifuged for 10 mins at 10,000g to pellet aggregated protein. Samples from the supernatant were 
run on SDS-PAGE and stained with InstantBlue. 
 
 
